SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Seeking Alpha / 13 minutes ago 1 Views

- ASCO Presentation to Highlight Preclinical Efficacy of SLS009 (tambiciclib) in ASXL1 Mutated Colorectal Cancer - 
- ASCO Presentation to Highlight Preclinical Efficacy of SLS009 (tambiciclib) in ASXL1 Mutated Colorectal Cancer -
Read more

Comments